BJL
IOVA icon

Brighton Jones LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Brighton Jones LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$159K Buy
+38,115
New +$145K ﹤0.01% 1277

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
OIC
Orion Investment Company St. Louis, Missouri $343M AUM 52.59% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Brighton Jones LLC's IOVA Position: Q2 2026 in Review

Brighton Jones LLC opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 38,115 shares worth $159K. The stake represents ﹤0.01% of the portfolio and ranks #1277 among its holdings.

147 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Brighton Jones LLC held 38,115 shares of Iovance Biotherapeutics worth $159K as of Q2 2026.
  • Iovance Biotherapeutics was a new Brighton Jones LLC position in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1277 holding.
  • 147 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.